MEDINDIA
English
हिन्दी
Español
français
中文
Tamil Nadu has received four lakh doses of COVID-19 vaccines, said Tamil Nadu Health Minister C.Vijayabaskar.
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
On Friday, Chief Minister K. Palaniswami requested Prime Minister Narendra Modi for an assured supply of at least 10 days' Covid-19 vaccine stock of about 20 lakh doses in advance to ensure that the vaccination drive in the individual sites is not affected and the people coming for the second jab get them on the due date.
Source-IANS
Clinical Trials to Resume With Rollout of COVID Vaccines
With a decline in the number of COVID-19 cases due to increasing vaccinations in the US and the UK, GlobalData expects clinical trials to resume more quickly in these countries.
With a decline in the number of COVID-19 cases due to increasing vaccinations in the US and the UK, GlobalData expects clinical trials to resume more quickly in these countries.
COVID Vaccines on Sale on Darknet for $250 to $1,200
Cybercriminals have posted sales advertisements for three major COVID-19 vaccines and the prices per dose range from $250 to $1,200, with an average cost of about $500, said a report.
Cybercriminals have posted sales advertisements for three major COVID-19 vaccines and the prices per dose range from $250 to $1,200, with an average cost of about $500, said a report.
Two COVID Vaccines Got Approved in India for Emergency Use
Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
